CD30-directed Antibody Interactions [MoA] - N0000182966

Pharmacologic Class Information

Pharmacologic Code N0000182966
Pharmacologic Name CD30-directed Antibody Interactions
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD30-directed Antibody Interactions

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD30-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
51144-050Adcetris Non-Proprietary Name: Brentuximab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE